% This is the RIPE Database query service.
% The objects are in RPSL format.
%
% The RIPE Database is subject to Terms and Conditions.
% See https://docs.db.ripe.net/terms-conditions.html
% Information related to 'AS31165'
% Abuse contact for 'AS31165' is '[email protected]'
aut-num: AS31165
as-name: PGF-AS
org: ORG-PA701-RIPE
import: from AS15857 accept ANY
export: to AS15857 announce AS31165
import: from AS5617 accept ANY
export: to AS5617 announce AS31165
admin-c: PC2191-RIPE
tech-c: PC2191-RIPE
status: ASSIGNED
mnt-by: RIPE-NCC-END-MNT
mnt-by: NETIA-MNT
mnt-by: PELION-MNT
created: 2004-03-11T15:00:16Z
last-modified: 2019-04-12T12:24:38Z
source: RIPE
sponsoring-org: ORG-NTS2-RIPE
organisation: ORG-PA701-RIPE
org-name: PELION S.A.
country: PL
org-type: OTHER
address: 91-342 Lodz, Zbaszynska 3
e-mail: [email protected]
abuse-c: AR25832-RIPE
mnt-ref: NETIA-MNT
mnt-by: NETIA-MNT
mnt-by: PELION-MNT
mnt-by: NASK-MNT
created: 2014-07-02T12:13:44Z
last-modified: 2022-12-01T16:42:03Z
source: RIPE
person: Pawel Ciezki
address: Polska Grupa Farmaceutyczna S.A.
address: ul. Zbaszynska 3
address: Lodz
address: Poland
e-mail: [email protected]
phone: +48 42 2533521
nic-hdl: PC2191-RIPE
mnt-by: NETIA-MNT
created: 2003-07-29T08:17:13Z
last-modified: 2021-12-29T23:03:35Z
source: RIPE
% This query was served by the RIPE Database Query Service version 1.114 (SHETLAND)